Prab: CSV import

2025-02-13T03:34:33Z

CSV import

← Older revision		Revision as of 03:34, 13 February 2025
Line 1:		Line 1:
	AM-2389		== AM-2389 ==

	'''AM-2389''' is a synthetic cannabinoid that acts as a potent and selective agonist for the [[cannabinoid receptor]] [[CB1 receptor\|CB<sub>1</sub> receptor]]. It is primarily used in scientific research to study the [[~~endocannabinoid system]] and its effects on the [[central nervous system]].~~		[[File:AM-2389_Structure.svg\|thumb\|right\|Chemical structure of AM-2389]]

	~~==Chemical Structure==~~
	AM-~~2389 is a derivative of the [[tetrahydrocannabinol]] (THC) structure, with modifications that enhance its selectivity and potency at the CB<sub>1</sub> receptor~~. ~~The chemical~~ structure of AM-2389 ~~is characterized by the presence of a [[naphthoyl~~]] ~~group, which is a common feature in many synthetic cannabinoids.~~

	[[~~File:AM-2389_Structure~~.~~svg\|thumb\|right\|Chemical structure of AM-2389~~]]		'''AM-2389''' is a synthetic cannabinoid that acts as a potent agonist of the [[cannabinoid receptor]]s. It is primarily used in scientific research to study the [[endocannabinoid system]] and its effects on various physiological processes.

	==~~Pharmacology~~==		=== Chemical Properties ===
	AM-2389 ~~exhibits high affinity for~~ the ~~CB<sub>1</sub> receptor~~, which is ~~predominantly found in~~ the ~~brain and central nervous system. This receptor is part~~ of ~~the~~ [[~~G protein-coupled receptor~~]] ~~family and plays a crucial role in modulating neurotransmitter release~~. The ~~activation~~ of ~~CB<sub>1</sub> receptors by~~ AM-2389 ~~leads~~ to ~~various physiological~~ and ~~psychological effects, including alterations in mood, perception~~, and ~~cognition~~.		AM-2389 is a derivative of the [[tetrahydrocannabinol]] (THC) structure, which is the principal psychoactive constituent of [[cannabis]]. The chemical structure of AM-2389 is designed to enhance its affinity and selectivity for the cannabinoid receptors, particularly [[CB1 receptor\|CB1]] and [[CB2 receptor\|CB2]].

	===Mechanism of Action===		=== Mechanism of Action ===
	~~As a CB<sub>1</sub> receptor agonist,~~ AM-2389 mimics the action of ~~endogenous cannabinoids~~ such as [[anandamide]] and [[2-arachidonoylglycerol]] ~~(2-AG)~~. ~~Upon binding to the receptor,~~ AM-2389 ~~induces a conformational change that activates intracellular signaling pathways, ultimately resulting in the modulation of~~ [[neurotransmitter]] release.		AM-2389 functions by binding to the cannabinoid receptors in the [[central nervous system]] and [[peripheral nervous system]]. This binding mimics the action of naturally occurring endocannabinoids, such as [[anandamide]] and [[2-arachidonoylglycerol]], leading to various physiological effects. The activation of these receptors by AM-2389 can influence [[neurotransmitter]] release, [[pain perception]], [[appetite]], and [[immune response]].

	==Research Applications==		=== Research Applications ===
	AM-2389 is utilized in research to explore the therapeutic potential of cannabinoid receptor modulation. Studies have investigated its effects on [[pain management]], [[~~appetite regulation~~]], and [[~~neuroprotection~~]]. Additionally, AM-2389 ~~serves as a tool~~ to ~~better~~ understand the role of the endocannabinoid system in ~~various physiological processes~~ and disease ~~states~~.		AM-2389 is utilized in research to explore the therapeutic potential of cannabinoid receptor modulation. Studies have investigated its effects on [[pain management]], [[neuroprotection]], and [[inflammation]]. Additionally, AM-2389 is used to understand the role of the endocannabinoid system in [[neurological disorders]] such as [[epilepsy]], [[multiple sclerosis]], and [[Parkinson's disease]].

	==Safety and ~~Legal Status~~==		=== Safety and Toxicology ===
	As a research chemical, AM-2389 is not approved for human consumption and is typically ~~restricted to~~ laboratory settings. ~~Its legal status varies by country, with some jurisdictions classifying it as a controlled substance due~~ to ~~its potential for abuse and psychoactive effects~~.		As a research chemical, AM-2389 is not approved for human consumption. Its safety profile is not well-established, and it is typically handled in controlled laboratory settings. Researchers must adhere to strict safety protocols to prevent accidental exposure.

	==Related Pages==		== Related Pages ==
	* [[Cannabinoid receptor]]		* [[Cannabinoid receptor]]
	* [[Endocannabinoid system]]		* [[Endocannabinoid system]]
	* [[Synthetic cannabinoids]]		* [[Synthetic cannabinoids]]
	* [[Tetrahydrocannabinol]]		* [[Tetrahydrocannabinol]]

	~~==Gallery==~~
	~~<gallery>~~
	~~File:AM-2389_Structure.svg\|Chemical structure of AM-2389~~
	~~</gallery>~~

	[[Category:Synthetic cannabinoids]]		[[Category:Synthetic cannabinoids]]
	[[Category:Research chemicals]]		[[Category:Research chemicals]]

Prab: CSV import

2025-02-11T21:20:29Z

CSV import

New page

AM-2389

'''AM-2389''' is a synthetic cannabinoid that acts as a potent and selective agonist for the [[cannabinoid receptor]] [[CB1 receptor|CB1 receptor]]. It is primarily used in scientific research to study the [[endocannabinoid system]] and its effects on the [[central nervous system]].

==Chemical Structure==
AM-2389 is a derivative of the [[tetrahydrocannabinol]] (THC) structure, with modifications that enhance its selectivity and potency at the CB1 receptor. The chemical structure of AM-2389 is characterized by the presence of a [[naphthoyl]] group, which is a common feature in many synthetic cannabinoids.

[[File:AM-2389_Structure.svg|thumb|right|Chemical structure of AM-2389]]

==Pharmacology==
AM-2389 exhibits high affinity for the CB1 receptor, which is predominantly found in the brain and central nervous system. This receptor is part of the [[G protein-coupled receptor]] family and plays a crucial role in modulating neurotransmitter release. The activation of CB1 receptors by AM-2389 leads to various physiological and psychological effects, including alterations in mood, perception, and cognition.

===Mechanism of Action===
As a CB1 receptor agonist, AM-2389 mimics the action of endogenous cannabinoids such as [[anandamide]] and [[2-arachidonoylglycerol]] (2-AG). Upon binding to the receptor, AM-2389 induces a conformational change that activates intracellular signaling pathways, ultimately resulting in the modulation of [[neurotransmitter]] release.

==Research Applications==
AM-2389 is utilized in research to explore the therapeutic potential of cannabinoid receptor modulation. Studies have investigated its effects on [[pain management]], [[appetite regulation]], and [[neuroprotection]]. Additionally, AM-2389 serves as a tool to better understand the role of the endocannabinoid system in various physiological processes and disease states.

==Safety and Legal Status==
As a research chemical, AM-2389 is not approved for human consumption and is typically restricted to laboratory settings. Its legal status varies by country, with some jurisdictions classifying it as a controlled substance due to its potential for abuse and psychoactive effects.

==Related Pages==
* [[Cannabinoid receptor]]
* [[Endocannabinoid system]]
* [[Synthetic cannabinoids]]
* [[Tetrahydrocannabinol]]

==Gallery==
<gallery>
File:AM-2389_Structure.svg|Chemical structure of AM-2389
</gallery>

[[Category:Synthetic cannabinoids]]
[[Category:Research chemicals]]

AM-2389 - Revision history

Prab: CSV import

Prab: CSV import